PTAB challenges

Here is an analysis of the PTAB history for U.S. Patent No. 9,281,314 B1.

Proceedings Overview

One inter partes review (IPR) has been filed against U.S. Patent No. 9,281,314 B1. The proceeding was terminated at the pre-institution stage for procedural reasons, meaning the patent has not yet been substantively reviewed by the Patent Trial and Appeal Board (PTAB). For a defendant, this means the '314 patent has not been "battle-tested" in a PTAB trial, and a full range of invalidity arguments remains available.

IPR2025-01009 — Unified Patents, LLC v. Palisade Technologies, LLP

• Type: Inter Partes Review
• Filed: 2024-05-09
• Status: Not Instituted - Procedural. The petition was denied for not complying with the procedural requirements for filing.
• Judge Panel: Not assigned, as the petition was denied before the institution phase.
• Petition Grounds: The petition alleged that claims 1–6, 8–13, and 15–20 of the '314 patent were unpatentable as anticipated (§ 102) or obvious (§ 103) over various prior art references.
• Institution Decision: Institution was denied on procedural grounds on 2024-05-30. The PTAB found that the petition was incomplete because it failed to include a mandatory "Statement of the Precise Relief Requested," which must identify each claim challenged and the specific grounds for each challenge. Because this is a statutory requirement under 35 U.S.C. § 312(a)(3), the defect could not be corrected, and the petition was denied without a decision on the merits of the invalidity arguments.
• Final Written Decision: Not applicable, as the IPR was not instituted.
• Settlement / Termination: The proceeding was terminated by the Board's denial of the petition. There was no settlement.
• Appeal: Not applicable. A decision to not institute an IPR is not appealable to the Federal Circuit.
• Defensive Value: This proceeding offers no direct defensive value, as the merits of the invalidity arguments were never considered by the PTAB. However, it alerts a potential defendant that the patent owner, Palisade Technologies, LLP, is actively enforcing the patent and that a defensive patent aggregator, Unified Patents, has taken an interest in it. The grounds and prior art raised in the denied petition may provide a useful starting point for a new invalidity challenge.

Strategic Summary

All claims of the '314 patent (1-20) remain valid and enforceable, as they are all untested before the PTAB. The single IPR filed against the patent was denied on a procedural technicality before the Board considered the substance of the prior art arguments.

This procedural denial has a significant impact on the estoppel landscape. Because no trial was instituted, the petitioner (Unified Patents, LLC) is not estopped under 35 U.S.C. § 315(e)(1) from re-petitioning on the same or other grounds. Likewise, a future defendant has no estoppel limitations arising from this proceeding and is free to challenge any claim of the '314 patent in a new IPR using any prior art or arguments they deem appropriate, including the very same ones raised in the denied IPR2025-01009 petition. The involvement of Unified Patents, a known defensive aggregator, suggests that the '314 patent is being asserted in a manner that has drawn the attention of the technology industry.

Recommended Next Steps

Since no claims have been invalidated, a defendant cannot rely on any prior PTAB proceeding for a quick resolution. The primary takeaway is that the '314 patent remains fully intact from a PTAB perspective.

• For a potential defendant: The key fact is that the PTAB has not yet reviewed the patentability of the claims. The petition filed in IPR2025-01009, although denied procedurally, is a public document and can be reviewed on the USPTO's Patent Trial and Appeal Board End-to-End (PTAB E2E) system. It may provide a valuable roadmap of potential invalidity arguments for a future challenge.
• No Active Proceedings: As of today, there are no active PTAB proceedings against this patent. A defendant should monitor for new filings but must assume all claims are valid for now and prepare a defense on the merits.
• Future IPR Strategy: A defendant considering filing their own IPR should carefully review the petition in IPR2025-01009 to understand the initial arguments and, more importantly, to avoid the procedural error that led to its denial. The Board's decision to deny the petition can be viewed here: Order Denying Institution, IPR2025-01009, Paper 6 (P.T.A.B. May 30, 2024).